OncoBeta

OncoBeta® GmbH is a medical device and radiochemical company based in Garching near Munich, Germany. The company specializes in developing and commercializing innovative therapies for skin cancer, particularly non-melanoma skin cancers (NMSCs). Its primary product, Rhenium-SCT® (Skin Cancer Therapy), is a non-invasive treatment that uses rhenium-188 to deliver targeted radiation to skin cancer lesions in a single session, offering an alternative to traditional surgical methods. Founded with a mission to create advanced therapies for skin cancer, OncoBeta emphasizes regulatory compliance and safety in its operations. The company targets markets with high incidences of NMSC, such as Australia, and has established partnerships, including a collaboration with GenesisCare, to enhance access to its therapies. OncoBeta serves healthcare providers and clinics focused on dermatology and oncology, providing them with less invasive treatment options for their patients.

• Employees37
• Founded2011